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ABSTRACT 
4-aminoquinoline antiplasmodials interfere with the biocrystallization of the malaria pigment, a key step 
of the malaria parasite metabolism. It is commonly believed that these drugs set stacking pi· · ·pi 
interactions with the Fe-protoporphyrin scaffold of the free heme, even though the details of the 
heme:drug recognition process remain elusive. In this work, the local coordination of Fe(III) ions in 
acidic solutions of hematin at room temperature was investigated by EXAFS spectroscopy in the 4.0-5.5 
pH range, both in presence and in absence of the antimalarial drug chloroquine. EXAFS results were 
complemented by DFT simulations in polarizable continuum media (PCM) to model solvent effects. We 
found evidence that a complex where the drug quinoline nitrogen is coordinated with the iron center 
might coexist with formerly proposed adduct geometries, based on stacking interactions. Charge-assisted 
hydrogen bonds among lateral chains of the two molecules play a crucial role in stabilizing this complex, 
whose formation is favored by the presence of lipid micelles. The direct Fe-N bond could reversibly block 
the axial position in the Fe 1st coordination shell in free heme, acting as an inhibitor for the crystallization 
of the malaria pigment without permanently hampering the catalytic activity of the redox centre. These 
findings are discussed at the light of possible implications on the engineering of drugs able to thwart the 
adaptability of the malaria parasite against classical aminoquinoline-based therapies. 
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GRAPHICAL ABSTRACT. Difference between chloroquine-containing and chloroquine-free EXAFS 
spectra reveal the existence of a direct Fe–N coordinative bond with heme. DFT simulations show that 
this complex is stable in the acidic vacuolar environment and unstable in the alkaline cytosol, where 
uncomplexed heme increases the cellular oxidative stress of the malaria parasite. 
 
 
4 
1. INTRODUCTION 
Malaria, one of the topmost worldwide parasitic diseases, is caused by protozoa of the genus 
Plasmodium, which infect human erythrocytes via the transmission through the Anopheles 
mosquitoes and digest host hemoglobin. Despite ongoing efforts to counteract the contagion, the 
emerging and spreading of parasite (cross-)resistance [1] is becoming a dramatically serious 
problem. [2] In particular, P. falciparum, the most virulent malaria parasite, evolved resistance 
against chloroquine (CQ, Scheme I(a)), [3–5] an important aminoquinoline-class drug, [6] while 
other antiplasmodials are becoming less and less effective. [7–9] The urgency of designing new 
drugs able to thwart the parasite adaptability is growing up due to the need of limiting the 
infection. Additionally, in the next decades, the climate changes could provoke fresh outbreaks of 
the disease in Western countries and new malaria parasite adaptation processes cannot be 
excluded. [10] 
 
Scheme I. Chloroquine (a), hematin (b) and heme dimer (c) chemical structures 
A possible weakness in the Plasmodium metabolic pathways resides in the fact that hemoglobin 
digestion releases free heme (Fe(II)-protoporphyrin IX, Fe(II)-PPIX). In the acidic (pH ≈ 4.5–5.0) 
digestive vacuole (DV) of the parasite, Fe-PPIX is present as monomeric hematin (Scheme I(b)), 
with partly dissociated propionic groups and oxidized Fe(III) active centres. This compound can 
be released into cytosol, where it takes part in cyclic Fenton-type redox reactions [11] generating 
reactive oxygen species (ROS) and increasing the cellular oxidative stress. [12,13] To detoxify 
free heme, the parasite promotes its dimerization through iron-carboxylate coordinative bonds 
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(Scheme I(c)) directly in the DV. [14,15] Dimeric heme then forms an insoluble solid known as 
β-hematin or hemozoin, which consists of triclinic (P1) pale yellow crystals [16] that give a 
characteristic colour to the skin of malaria-infected people. It has been suggested that lipid 
nanodroplets dispersed in the DV might play a key role in the hemozoin self-assembly, [17,18] a 
process catalysed by a specific histidine-rich polymerase. [19,20]  
Among other formerly proposed antiplasmodial mechanisms, [21,22] it is nowadays widely 
accepted that 4-aminoquinoline (AQ) drugs, such as CQ (Scheme I(a)), interfere with the parasite 
detoxification pathway. [23] A recent study of crystallization kinetics of β-hematin in presence of 
CQ argued [24] that the drug should act by binding at the fastest-growing crystal faces of 
hemozoin. Else, it is believed that CQ could hamper the heme dimerization in solution, even 
though there is no general consensus on the structure of the heme:CQ complex. [25–27] UV and 
UV-vis spectroscopy results on heme/CQ solutions are usually interpreted [28,29] by assuming 
that the rigid fused aromatic structure in the drug quinoline moiety interacts with the 
protoporphyrin scaffold through stacking pi⋅⋅⋅pi interactions. This structural model was 
corroborated by semiempirical AM1 [27] and PM3 [30] simulations. Also EXAFS [31,32] and 
NMR [25] experiments, although having been performed respectively on mesohematin anhydride 
solutions and in alkaline conditions, agree with this interaction geometry. On the contrary, high-
grade DFT simulations suggest that either a water molecule or the OH– group in hematin (Scheme 
I(b)) might act as a bridge between the iron centre and the secondary amine of CQ. [33] Direct 
Fe-N interactions were even proposed on the basis of solid state 13C and 15N NMR outcomes. [26] 
Attempts to produce crystalline heme:CQ adducts [24] were only partly successful, as up to now 
they led to the crystallization of a new β-hematin DMSO-solvated phase. On the contrary, adducts 
of Fe(III)-PPIX with other antimalarials (halofantrine,[34] quinine and quinidine [35]) have been 
successfully crystallized and their solid-state structures reported. Interestingly, in these structures 
Fe is always directly coordinated with a donor (O, N) atom of the drug. A very recent quantum 
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mechanical study of porphine and Fe-PPIX complexes accordingly predicted a direct Fe-N 
interaction when unsubstituted quinoline was considered as a ligand. [36] 
Till now, no unequivocal evidence exists that secure the most probable heme:CQ interaction 
geometry. On the other hand, a complete understanding of this recognition process at the 
molecular and sub-molecular level is desirable to elucidate what kind of intermolecular 
interactions determine the antiplasmodial ability of CQ. To shed light on this issue, we report on a 
combined experimental and theoretical study of the hematin/CQ system in conditions as close as 
possible to the chemical environment of the Plasmodium DV. To elucidate the role of 
nanodispersed lipidic phases, samples including a tensioactive (sodium dodecyl sulphate, SDS) at 
its critical micellar concentration (CMC) were also compared with analogue tensioactive-free 
specimens. High-grade DFT simulation were crucial to interpret the very weak trends found by 
EXAFS experiments. This work represents the first direct and systematic investigation of the 
drug:substrate recognition process in the heme:CQ system, performed at a pH range comparable 
to the pH of the Plasmodium digestive vacuole. The most striking results of the present 
contribution are discussed in the perspective of engineering novel CQ-analogue drugs 
characterised by an improved specificity and effectiveness against malaria desease. 
2. METHODS 
2.1 Preparation of the solutions.  
Solid powders of reagent-grade hematin porcine, CQ diphosphate salt and sodium dodecyl sulfate 
(SDS) were purchased by Sigma-Aldrich. The solutions were prepared by dissolving hematin in 
dimethylsulfoxyde (DMSO, reagent grade, Aldrich) and mixing 1:1 with an aqueous citrate buffer 
(final concentration: 0.1 M) to set the desired pH (4.0, 4.5, 5.0 and 5.5). The employment of a 
fully aqueous environment was not suitable, as hematin porcine was poorly soluble in water at the 
selected operative concentrations (see infra). For each pH value, three solutions were prepared, 
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consisting of hematin (H), hematin plus CQ (HC), and hematin plus CQ and SDS (HCS). 
Individual samples are labelled as X(pH), with X=H, HC or HCS. Where not otherwise specified, 
nominal concentration of hematin and CQ were set at 5 and 1 mM, respectively. More 
concentrated CQ solutions were also tested, but no significant differences were evident neither in 
the signal shape, nor in the fitting results (see Section S1 in the Supplementary Information, SI). 
The drug concentration is comparable with that reported in vivo within the DV of Plasmodium 
based on the estimated CQ vacuolar accumulation ratio. [27] In SDS-containing solutions, the 
critical micellar concentration of the tensioactive (8 mM) was set to have lipidic micelle 
coexisting with other reactants.  
 
2.2 EXAFS experiments.  
Extended X-ray Absorption Fine Structure (EXAFS) spectra across the Fe Kα absorption edge 
(7.11 keV) were carried out at the BM26A (DUBBLE) station of the ESRF facility in Grenoble 
(FR). All the spectra were recorded at room temperature in the 6.9-7.7 keV energy range, 
allowing a practical maximum resolution of 10.0 Å–1 in k space. Glass capillaries (∅ 1.5 – 2.0 
mm, ≈ 3/4 filled) were employed to host solutions. After some preliminary tests in transmission 
geometry, fluorescence mode was selected to maximize the signal intensity. See Section S1 SI for 
details concerning data collection (S1.1), and fitting (S1.2 – S1.5). 
Great care was taken to avoid degradation of the solutions. All the specimens were either stored in 
the dark at T ≤ 4°C prior being sent to the experimental station, or measured as freshly prepared. 
To limit radiation damage (Section S1.1.2 SI), each recorded spectrum was obtained upon 
averaging a total of 6 scans, obtained from 2-3 repeated scans on a sequence of 2-3 capillaries 
filled with the same solution.  
The Horae suite of programs, [37] based on the IFEFFIT library, [38] was used throughout data 
processing and fitting. The E0 edge values were always set at the inflection point of the Fe Kα 
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transition. DFT-optimized structures of hematin, Fe(III)-protoporphyrin dimer and a sensible 
Fe(III)-protoporphyrin:CQ adduct (see Section 3.2 below and Section S1.3 SI) were employed as 
starting models to interpret the fine structure functions, whereas the available crystallographic 
data [16] were used to model the possible presence of hemozoin crystals. Hereinafter, we will 
refer to these structural models by Roman numerals as hematin monomer (i), heme dimer (ii), 
hemozoin (iii) and FePPIX:CQ adduct (iv). They were employed to perform both shell-by-shell 
and multi-shell fittings. Details on least-squares refinements can be found in Sections 4.2.1 and 
4.2.2 below, whereas complete lists of statistical agreement factors and refined parameter values 
are available to the interested reader in Section S1.3 SI and Tables S1-S15 SI.  
  
2.3 UV-Vis experiments.  
The effect of CQ on the hematin-containing solutions was checked through UV-Vis spectroscopy. 
Measurements were performed by using a SPECTRO LGS53 UV-Vis spectrophotometer in the 
wavelength range of 300–450 nm. The concentrations of hematin and CQ drug were both 12 µM.  
 
2.4 Quantum mechanical DFT simulations.  
Quantum mechanical DFT calculations were performed by the Gaussian09 suite of programs [39] 
with the hybrid (U)B3LYP [40–43] functional and the triple-zeta 6–311G(p,d) basis set. [44] 
Calculations were performed in polarizable continuum media (PCM) [45] to take into account 
solvent effects at a reasonable computational cost. Geometry relaxations were performed both in 
water and in n-octanol as a model of an apolar environment. According with EPR and Mössbauer 
evidence, the iron centre was modelled in its oxidized form (Fe(III)) with spin multiplicity S = 
5/2. [46,47] Main numerical results are summarized in Section S2 SI. 
Fe(III)-protoporphyrin adducts with various chemical species, such as water, OH– or  chloroquine 
as axial ligands, were considered (see Section 4.3 below). To ensure that true minima on the 
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potential energy surface (PES) were reached, a full analysis of the normal vibration modes of each 
refined structure was carried out. Vibrational partition functions were also computed to provide 
thermochemical estimates [48] for ligand exchange and acid-base reactions on the iron centre. 
3. RESULTS  
Hereinafter, relevant chemical compounds are named by highlighting (i) the axial ligand in the 
iron first coordination shell, if present, and/or (ii) the protonation degree of the main acid/basic 
centres. For example, neutral hematin is indicated as FePPIX(OH)H2, while FEPPIX(OH)H– and  
FePPIX(OH)2– mean that either or both the propionic groups have lost their protons. Similarly, 
FePPIX(H2O)H2+ represents the protonated hematin molecule, with a water molecule coordinated 
on the Fe centre. In this notation, neutral chloroquine is written as CQ, while CQH+ and CQH22+ 
are the corresponding single and double protonated forms.  
 
3.1 UV-vis results 
The recorded UV spectra (Figure 1) are identical to those reported in a same previous paper [49] 
carried out on 40% DMSO buffered aqueous solution of hematin and CQ in different 
stoichiometric ratios. In the presence of the drug we detected the same decrease of the Soret band 
of hematin at λ ≈ 400 nm. According with Literature, [28,30,49Errore. Il segnalibro non è definito.] such an 
effect was attributed to the interference between the CQ drug and the heme monomer-dimer 
system, and in particular to the formation of some kind of donor-acceptor FePPIX-
aminoquinoline supramolecular complex. 
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FIGURE 1. Colour online. Left: UV–vis spectra at pH = 5.0 of a 1:1 DMSO/aqueous citrate 
buffer solution (0.02 M) of CQ (red), hematin (black) and the binary mixture CQ/hematin (light 
blue). Right: Comparison of the spectrum of the binary mixture CQ/hematin (light blue) with the 
point-by-point sum signal computed from CQ and hematin spectra on the left (black, dashed).  
 
3.2 EXAFS analysis.  
Figure 2 shows the EXAFS fine structure functions, χ(k), and their corresponding Fourier 
transforms χ(R), for the pH = 5.0 series, taken as a representative case for the conditions of the 
DV environment. Analogous pictures for the other samples in the 4.0-5.5 pH range, including 
least-squares fits against the applied structural models, can be found in Section S1 SI (Figures S5-
S12 SI), together with least-squares agreement factors (Tables S2-S4 SI) and final refined 
parameters (Tables S5–S15 SI).  
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FIGURE 2. Colour online. k2-scaled EXAFS fine structure functions χ(k) (left) and their Fourier 
transforms χ(R) (right) for the H(5.0), HC(5.0) and HCS(5.0) samples. Measured data are shown 
as blue dots, connected through broken lines as guides for the eye. The smoothed curves are 
functions employed to reproduce the experimental signals, as computed from the real-space fitting 
of different structural models against each dataset (blue: monomeric hematin, (i); red: heme 
dimer, (ii); green: crystalline hemozoin, (iii)). 
 
At a first glance, the experimental χ(k) curves in Figure 2 look quite similar. The same holds true 
also for H, HC and HCS sample series at other pH’s (Figures S5-S8 SI). Real-space Fourier 
transforms invariably show three main peaks at R ≈ 2.1, 3.0 and 4.2 Å, plus minor oscillations 
hardly distinguishable from the Fourier noise due to k-space filtering. Accordingly, the 
experimental data might be fitted quite equally well by structural models based on monomeric 
hematin (i), dimeric heme (ii) and hemozoin crystals (iii). For example, the monomeric hematin 
model (i) gives R agreement factor / reduced χ2 parameters as low as 0.017/32.6, 0.028/13.5 and 
0.021/26.3 for the H(5.0), HC(5.0) and HCS(5.0) samples. To the sake of comparison, the same 
values become 0.016/28.0, 0.037/17.9 and 0.023/30.3 when computed on the basis of the dimeric 
heme model (ii). Crystalline hemozoin (iii) provides, on average, slightly worse statistics (Tables 
S2-S4 SI).  
Neither obvious trends nor clear hints on what structural model(s) should be preferred to interpret 
the experimental data are easily recognizable (Tables S2-S4 SI). This is due to the fact that the 
local environment of the iron ion, which is fixed by the rigid protoporphyrin scaffold, necessarily 
dominates the EXAFS signals. Therefore, the main features of the iron coordination geometry 
must be conserved in all the examined samples. This implies that the recorded spectra are always 
similar to each other, and the effect of the drug should manifest in more subtle features 
throughout the dominating contributions of PPIX moiety. Besides, the picture is even more 
complicated by the fact that different iron complexes (monomeric hematin, dimeric heme, 
hemozoin and possible heme:CQ adducts) might coexist in solution. Nevertheless, some 
systematic trends are recognizable when the chemical composition of the solutions is varied.  
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Actually, most CQ-containing HC and HCS specimens have lower E0 edge energies than the CQ-
free ones (H) at a given pH (Table 1). Average <E0> values for the H, HC and HCS solutions 
throughout the 4.0-5.5 pH range turn out to be as high as 7125.6(5) eV, 7123.9(4) eV and 
7124.3(3) eV respectively.  
Table 1. E0 edge values (eV) for the Fe Kα transition in H, HC and HCS solutions as a function of pH.  
pH Ha HCb HCSc 
4.0 7126.5 7123.5 7125.0 
4.5 7124.5 7123.0 7124.0 
5.0 7126.5 7124.0 7124.5 
5.5 7125.0 7125.0 7123.5 
a
 Hematin-only solution 
b
 Hematin plus chloroquine 
c
 Hematin plus chloroquine and SDS 
 
As each H, HC and HCS spectrum at a given pH is obtained from the average of 4-6 scans on 2-3 
different solutions (see Section 2.2 above), it is improbable that this E0 shift be due to random 
errors. Rather, though very small, in our opinion these differences likely rely on a true physical 
effect. Following other groups [31], we attributed them to a slight difference in the chemical 
environment of the iron absorber. The latter should be related to the presence of CQ in the reaction 
mixture. Accordingly, we did not apply any a priori shift to the EXAFS-estimated edge energies in the 
subsequent analysis.  
 
FIGURE 3. Colour online. Point-by-point difference (green) of the measured EXAFS fine 
structure functions of the HC(5.0) (red) and H(5.0) (black) specimens. See Figure S13-S16 SI for 
the corresponding curves at different pH’s. 
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To single out statistically significant differences among the spectra recorded in the presence (HC, HCS) 
and in the absence (H) of chloroquine, the measured fine structure function of the CQ-free solution H 
might be subtracted from that of the CQ-containing one, e.g. HC, at the same pH. The residual signal 
should then convey the amount of information by which the two pristine spectra differ from each other, 
i.e. should enclose the effect of CQ on the environment of the iron ion. Figure 3 shows the point-by-point 
difference of the measured EXAFS fine structure functions of the HC and H solutions at pH = 5.0. An 
equivalent curve is obtained when the H(5.0) signal is subtracted from the HCS(5.0) one (Fig. S15(b) SI). 
In general, the difference signal shows neatly structured oscillations at low k values, due to the very small 
phase shift between the two original curves that can be traced back to the small differences in E0 
discusses above. On the contrary, at higher k modules these oscillations are smeared into featureless 
noise. It can be safely excluded that the difference signal in Fig. 3 could be attributed to other compounds 
in solution rather than CQ, such as DMSO or the citrate buffer, as both the HC and H samples contained 
exactly the same amount of these species within the statistical error. Moreover, identical findings hold 
true also when other samples are considered: A very similar difference signal is almost invariably 
retrieved throughout the whole 4.0-5.5 pH range, when either HC-H or the HCS-H differences are taken 
into account (Section S1.4 SI). However, difference spectra depend on the average structure of the solute 
throughout its accessible conformation spaces, which are likely different in H and HC (or HCS) samples. 
Besides, solvent effects and possible inhomogeneities of the probed specimens – all of them being 
potential sources of undetected but unavoidable systematic errors – might affect either the small detected 
phase shift or the intensity of the oscillations (Figures S13-S16 SI). For these reasons, extracting 
quantitative information from the difference signals is not feasible. Rather, on a more qualitative level, 
we note that two main peaks (A, C) at R ≈ 1.9 and 2.8 Å, plus a neat shoulder (B) at ≈ 2.4 Å, appear in the 
real-space Fourier transform of the difference signal (Figure 4, left).  
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FIGURE 4. Colour online. Left: Real-space Fourier-transformed HC(5.0)-H(5.0) difference 
signal shown in Figure 3.. Right: Ball-and-stick representation (C: grey, N: blue, Cl: light green, 
Fe: brown) of the approximate (see text) interaction geometry for the quinoline ring of CQ and the 
FePPIX structure. –R stands for the CQ alkyl side chain. A, B and C label the features of the 
difference curve which correspond with the Fe–X (X = C, N) next neighbour distances on the 
right. Diamond v3.2k, © 1997-2014 Crystal Impact GbR, Bonn, Germany was employed 
throughout to draw ball-and-stick pictures. 
 
Various models, based on possible approaching modes of the CQ molecule in the neighbourhood of the 
Fe(III) centre, were considered to interpret the main features in χ(R) (Figure 4, left). We eventually 
realized that such features, despite corresponding to approximate Fe-backscatterer distances, are 
qualitatively in accordance with the geometries of both the quinoline:porphine complex, as predicted by 
quantum mechanical calculations [36], and other PPIX:4-AQ drugs adducts, as determined by single-
crystal X-ray diffraction experiments [34,35]. This prompted us to look for a FePPIX:CQ complex 
consistent with this interaction geometry, i.e. implying a direct Fe-N coordinative bond (Figure 4, right). 
Obviously, no quantitative insights into the heme:CQ recognition process can be obtained by the study of 
the difference signal alone. We therefore employed the information on the relative orientation between 
the quinoline and PPIX rings here hypothesized to build a suitable starting point for subsequent quantum 
mechanical DFT optimizations (see infra). 
 
4. DISCUSSION: Is a Fe–N coordinative bond directly involved in the CQ:heme recognition 
process?  
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4.1 Quantum mechanical simulations.  
To improve the accuracy of the proposed structural model (Figure 4, right), the adduct structure 
was optimized through DFT-PCM calculations of the isolated complex (see Section 2.4 above). 
Water and n-octanol were considered as solvents, the latter having being chosen to model the 
apolar environment due to lipid micelles in SDS-containing specimens. As for the starting 
geometry, we employed monoprotonated CQH+ to bind the ferric centre through the free 
quinoline N atom. In general, the accessible conformation space for possible heme:CQ interacting 
pairs is very large, as the side hydrocarbon chain in CQH+ has a significant torsional freedom 
even when N is coordinated to Fe. According to Literature findings, [25,33,50,51] to reduce the 
complexity of the problem to an affordable level we looked for favourable interaction geometries 
that included attractive N-H⋅⋅⋅O charge-assisted hydrogen bond (CAHB) interactions among the 
tertiary amine and the free heme propionate group.  
 
FIGURE 5. Colour online. Ball-and-stick representation of the B3LYP 6-311G(p,d) optimized geometry 
for a stable FePPIX(CQH)H+ complex in water (a) and in n-octanol (b). Short NH⋅⋅⋅O, CH⋅⋅⋅O and CH⋅⋅⋅N 
intermolecular hydrogen-bonded contacts are shown as dashed red lines and the corresponding distances 
in Å highlighted. The usual colour code was employed to represent different atoms (green: chlorine, 
brown: iron; red: oxygen; blue: nitrogen; grey: carbon and white: hydrogen). 
 
Figure 5 shows the fully relaxed geometries for the FePPIX(CQH)H+ adduct corresponding to the 
true minima found by DFT simulations in water (a) and n-octanol (b) (Table S18 SI). The two 
complexes share the same basic structure, with the main molecular planes of PPIX and quinoline 
moieties lying approximately orthogonal to each other. The most striking difference is a 
significant reduction in the NH···O HB contact distances for the heme:CQ adduct in octanol (Fig. 
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5 and Tables S19-S20 SI). This effect is due to the expected increase in the CAHB strength in the 
low dielectric constant environment provided by the less polar solvent. On the contrary, the 
chemical nature of the solvent has clearly a minor effect on the Fe coordination environment, with 
changes in contact lengths between the FePPIX ring and the quinoline system not exceeding 10– 2 
Å.  
 
4.2 Performance of the DFT structural models against EXAFS data.  
4.2.1 First-shell fitting. To check to what extent the DFT-relaxed geometries shown in Fig. 5 
reproduce the experimental data, we performed real-space fittings of the Fourier-transformed 
EXAFS fine structure functions (Tables 2–3, Figure 6). We focused just on the first peak at ≈ 2.0 
Å (Figure 2, right), which is due to the convolution of structural contributions coming from the 
Fe(III) first-shell ligand sphere. On the basis of X-ray diffraction experiments on chloroquine-
analogue complexes [34,35], solid state NMR findings [26] and our EXAFS-assisted DFT 
simulations (Sections 3.1 and 4.1 above), the first-sphere ligands are expected to be directly 
involved in the drug:substrate recognition process, while farther coordination shells should be 
much less affected by the presence of CQ. In-water DFT-optimized structures of (i) isolated 
hematin (FePPIX(OH)H–), (ii) heme dimer (FePPIX(FePPIXH)H), (iii) crystalline hemozoin 
([FePPIX(FePPIXH)H]n→∞) and FePPIX(CQH)H+ complex (iv)  (Figure 5, left) were employed to 
compute starting estimates for the corresponding Fe–X (X = O, N) backscattering paths. As the 
Fe(III) ions in the PPIX scaffold exploit a C4v-like distorted square-pyramidal coordination, two 
independent ∆r corrections were applied to account for axial and equatorial ligands in models (i)–
(iii). When the heme:CQ FePPIX(CQH)H+ adduct model (iv) was considered, a third ∆r 
parameter was added to simulate higher-R contributions due to the Fe-Nq backscattering path 
involving the quinoline Nq Nitrogen of CQ. Actually, this complex is expected to coexist in 
solution with drug-free substrates, such as monomeric hematin or dimeric heme.  
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Figure 6 and Table 2 show the structural parameters retrieved from the χ(R) signals fittings the 
hematin monomer (i) and heme:CQ adduct (iv) systems against H, HC and HCS sample series. 
Results corresponding to models (ii) and (iii) are very similar to those from model (i) and are 
reported in the Supporting Information (Figure S4 SI and Table S1 SI).  
 
Table 2. Refined parameters for first-shell fittings against H, HC and HCS samples in the 4.0–5.5 
pH range, with estimated standard deviations (e.s.d.’s) in parentheses. R- and k-windows were as 
large as 1.2-2.6 Å and 2-12 Å-1, respectively. Hanning (dR = 0.0) and Kaiser-Bessel (dk = 1.89) filters 
were employed in the real and reciprocal spaces, giving a total of 16 independent points. Models (i) and 
(iv) were employed to interpret H and HC/HCS datasets, respectively. For the sake of comparison, the 
iron-ligand first-shell distances from DFT calculations in water are d[Fe–O] axial = 1.88 Å, <d[Fe-N]> 
equatorial = 2.071(3) Å, and d[Fe–Nq] axial = 2.12 Å. 
 
 
Sample 
d[Fe–O]  
axial / Å 
<d[Fe-N]>  
equatorial/ Å 
d[Fe–Nq]  
axial / Å c 
S02 σ /Å2 R d 
H(4.0) a 1.86(8) 2.03(2) // 0.9(3) 0.006(6) 0.0715  
HC(4.0) b 1.9(1) 2.02(2) 2.5(1) 1.1(6) 0.009(9) 0.0561  
HCS(4.0) b 1.9(2) 2.01(5) 2.4(1) 1.6(8) 0.02(1) 0.0327 
H(4.5) a 1.83(8) 2.02(2) // 1.0(4) 0.007(6) 0.0634 
HC(4.5) b 1.84(9) 2.03(2) 2.5(1) 1.2(9) 0.008(8) 0.0723   
HCS(4.5) b 1.8(1) 2.04(2) 2.5(1) 1.2(9) 0.009(8) 0.0826 
H(5.0) a 1.9(3) 2.00(5) // 1.2(5) 0.02(2) 0.0409 
HC(5.0) b 1.8(1) 2.03(2) 2.5(1) 1(1) 0.011(9) 0.0693 
HCS(5.0) b 1.9(1) 2.05(2) 2.5(1) 1.2(8) 0.009(8) 0.0805 
H(5.5) a 1.86(9) 2.04(2) // 0.9(4) 0.005(6) 0.1090 
HC(5.5) b 1.9(1) 2.04(3) 2.5(2) 1.2(8) 0.010(9) 0.0878 
HCS(5.5) b 1.8(1) 2.02(3) 2.5(2) 1(1) 0.01(1) 0.0643 
a
 Fitting against the hematin monomer FePPIX(OH)H– model (i) at the in-water optimized DFT geometry.  
b
 Fitting against the The FePPIX(CQH)H+ adduct model (iv) (Figure 5) at the in-water optimized DFT geometry. 
c
 Nq is the quinoline Nitrogen of the CQ molecule. 
d
 Statistical agreement factor. 
 
The agreement among the refined structural parameters shown in Table 2 and the corresponding 
theoretical estimates is generally good. The Fe–Nq distances are clearly overestimated, even 
though their estimated standard deviations (e.s.d.’s) are so large that the theoretical expected 
values are retrieved within 2-3 e.s.d.’s in most cases.  
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FIGURE 6. Colour online. χ(R) functions (black) for 1.2 Å ≤ R ≤ 2.6 Å, as computed from the 
EXAFS spectra of H, HC and HCS samples in the 4.0–5.5 pH range. The least-squares fitted 
contributions due to paths belonging to the Fe first coordination shell are also shown (red: Fe–O 
axial; green: <Fe–N> equatorial; light blue: Fe–Nq axial, Nq being the quinoline Nitrogen of CQ). 
The specs of the least-squares models are the same as in Table 2. 
 
From Figure 6, it is evident that the square pyramidal first coordination shell of Fe in the PPIX 
scaffold dominates the χ(R) signal: Compare for example the individual path contributions for 
Fe–O axial (red) and Fe-N equatorial (green) scatterers in H samples with those in HC and HCS 
ones. As expected, the hypothesized Nq ligand provides just a minor correction to the χ(R) 
function. Accordingly, the corresponding contribution due to this path (light blue curves in Figure 
6) is always very broad, and in fact its high variance translates into the high estimated standard 
deviations of the d[Fe–Nq] values in Table 2.  
Yet, the following points are also worth of being noted. First, the maximum of the first-shell peak 
shows a slight tendency to be systematically shifted towards higher R backscattering lengths upon 
the addition of either CQ, or CQ and SDS. Second, the peak of HC and HCS samples is 
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systematically broader than in H solutions. The only exception is the pH = 5.0 series, whose 
H(5.0) parent solution shows an exceptionally broad first-shell peak compared with other H 
specimens. We note, however, that that even in this case the signals from HC(5.0) and HCS(5.0) 
solutions are neatly shifted towards higher R values with respect to H(5.0). These evidences might 
be traced back to the increasing importance of the high-R contribution of the Fe-Nq axial bond 
when the drug (and/or SDS) is present. It is improbable that such changes are due to pi· · ·pi 
heme:CQ interactions, as the latter are expected to take place at considerably longer distances 
from the iron atom. For example, fittings against NMR data [25] give an estimate of 3.9(2) Å for 
the Fe–Nq distance in the heme:CQ adduct.  
Unfortunately, the difference we observe can be hardly translated into a quantitative model, as the 
improvement of the fit quality against the HC and HCS data upon adding the Fe–Nq contribution 
is only marginal. Table 3 lists the individual agreement R factors, as computed after applying 
models (i)–(iv) to each chloroquine-containing HC and HCS dataset. Model (iv) invariably shows 
a slight improvement in the final R factor, as expected due to its higher number of variable 
parameters. To assess whether such an improvement is also statistically significant, the Hamilton 
R-test [52] was performed (Table 3, last column). Interestingly, the test is always satisfied, but the 
confidence level is generally low. It should be remarked that the EXAFS spectra here studied 
were recorded in dilute solution at room temperature. 
Table 3. Agreement R factors when different structural models are applied to real-space EXAFS datasets 
H, HC and HCS. Global fitting parameters are the same as in Table 2 above. Models (i)–(iii) rely on 13 
variables, which become 14 for the heme:CQ adduct one (iv) (see text). The number of independent 
points is always 16. 
 
Model → 
Sample ↓ 
Hematin  
monomer (i) 
Hematin  
dimer (ii) 
Hemozoin  
(iii) 
FePPIX(CQH)H+ 
adduct (iv) 
Average Hamilton 
significance level a 
HC(4.0)  0.0705  0.0677  0.0692  0.0561  50.0 % 
HCS(4.0)  0.0409 0.0441  0.0428  0.0327 66.7 % 
HC(4.5)  0.0845  0.0801 0.0817  0.0723   50.0 % 
HCS(4.5)  0.0987  0.0958  0.0968  0.0826 50.0 % 
HC(5.0)  0.0959  0.0916  0.0940  0.0693 75.0 % 
HCS(5.0)  0.0945  0.0927  0.0933  0.0805 50.0 % 
HC(5.5)  0.1076  0.1070  0.1076  0.0878 50.0 % 
HCS(5.5)  0.0792  0.0776  0.0790  0.0643 50.0 % 
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a
 Confidence level at which the Hamilton significance test [52] is satisfied, given as the average of the individual 
confidence levels for comparisons of model (iv) with models (i), (ii) and (iii), respectively. The higher this parameter, 
the higher the probability that the slight improvement of the agreement factor due to model (iv), which employs one 
more variable than models (i)–(iii), is statistically significant. 
 
Therefore, thermal motion issues make very difficult to extract accurate and quantitative 
information from the least-squares fittings alone. On the other hand, we have weak, although 
systematic, indications that i) the presence of CQ (and of CQ plus SDS) somehow influence the 
first coordination shell of the iron absorber and ii) the proposed heme:CQ adduct model (iv) 
performs slightly better than (i)–(iii) in interpreting the measured signal.  
4.2.2 Multi-shell fitting. It is instructive to explore the outcomes of multi-shell fittings as a 
function of the chemical composition of the probed solutions. This is indeed the method recently 
employed to interpret EXAFS spectra collected on mesohematin anhydride:CQ systems [31,32]. 
Moreover, due to above sketched difficulties in retrieving accurate geometric parameters at 
atomic resolution from experimental data, we might inspect at the performances exploited by each 
DFT model in reproducing a wider portion (1.0 Å ≤ R ≤ 5.0 Å) of the χ(R) function. In this way, a 
greater number of independent data can be taken into account, granting more flexibility to the 
model and allowing to retrieve at least qualitative hints on what species among the (i)–(iv) above 
described are favoured, on average, in a given chemical environment. Full details of the least-
squares procedures, including individual statistics of the various fits, refined parameters (Tables 
S2–S15 SI) and first-shell coordination distances (Tables S21–S31 SI), can be found in Sections 
S1.3 and S3 SI.  
To compare the quality of the various models on the same grounds, especially when applied to 
different samples, we define here for the first time a ‘score function’ for the i-th model, Si, based 
on the reduced χ2 parameters according to: 
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In (1), each sum runs over the N models applied to a given spectrum, n is an integer normalization 
constant to have ΣiSi = 100 and χi2 is the reduced χi2 of the i-th model. The lower an individual 
χi2, the higher will be the corresponding score Si, meaning that that model provides a better fit 
against the experimental fine structure function of a given sample than any other model with a 
lower score. Neither clear nor systematic trends are detectable among individual Si (Figure S17 
SI) estimates as a function of the pH. Therefore, just the average scores of each model throughout 
each pH series were considered. Figure 7 summarizes the computed scores for the models above 
listed against the H, HC and HCS sample series. 
 
FIGURE 7. Color online. Suitability of different structural models in reproducing experimental EXAFS 
data for the H, HC and HCS sample series. Fitting ranges were always 1.0 Å ≤ R ≤ 5.0 Å and 2.0 Å –1 ≤ k 
≤ 10.0 Å –1, corresponding to 25 independent data. Models (i)–(iii) employed 18 independent variables, 
which became 20 when model (iv) was considered.The higher the score parameter (eq. (1)), the better that 
model fits the specific sample that it is being considered (see text). Models (i)–(iv) described in Section 
4.2.1 above were taken into account. Each bar comes from the average of individual score functions 
throughout the 4.0–5.5 pH range. Vertical lines correspond to 1 estimated standard deviation (e.s.d.).  
 
Looking at trends of mean values in Figure 7 rather than at individual measurements (Figure S17 
SI), some interesting indications can be retrieved. For example, when the drug is not present (H 
solution), models (i) and (ii) differ by ≈ 2 e.s.d.’s, with the heme dimer performing slightly better. This is 
no longer true when chloroquine is added to the mixture, as in HC solutions all the four models are, 
on average, equally performant. Comparing the HC series with the HCS out, on the contrary, it is 
evident that the presence of SDS significantly enhances the performances of the heme:CQ adduct 
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model, while the hemozoin model (iii) becomes absolutely the worst performing one. Incidentally, the 
fact that model (iii) invariably shows a poorer score with respect to (i) and (ii) (Figure 7) could be related 
to the absence of chemical promoters of the heme polymerization [19,20] in our model chemical mixture. 
The Hamilton R-test [52] is always satisfied when the model with more parameters (heme:CQ 
adduct) is compared with the roughly equally-performant models with less parameters, such as the 
hematin monomer (i) or dimer (ii) ones. The average significance level for all the samples indeed 
amounts to 80.5 ± 0.1% (comparison with model (i)) and increases up to 86.8 ± 0.1% upon 
comparison with model (ii). See Section S1.5 SI for more details. 
In conclusion, the presence of lipidic micelle somewhat favours the formation of the heme:drug 
complex, discouraging at the same time the appearing of hemozoin crystals. This could be related 
to the increased strength of the CAHB non-covalent interactions among side chains (see above) in 
a low dielectric constant medium. According also with Literature findings, [53] the overall 
chemical composition of the DV environment (e.g. the presence of lipidic phases) appears to be 
more determinant than pHDV alone for the molecular recognition process. It should be stressed 
that we do not demand the proposed model for the FePPIX(CQH)H+ complex as the only 
possible. Former spectroscopic (EXAFS, NMR and UV-Vis) evidence implies that the setup of 
pi⋅⋅⋅pi stacking interactions between the quinoline moiety of CQ and the FePPIX aromatic system 
is indeed probable and it cannot be excluded that our proposed Fe–N interaction geometry coexist 
with stacked heme:CQ adducts in solution. 
 
4.3 Suitability of the heme:drug complexation in the DV chemical environment.  
To verify whether the formation of the proposed FePPIX(CQH)H+ complex is possible in 
practice, it is important to take into account what reactions, and in particular which acid-base 
equilibria, are likely to occur in the Plasmodium vacuolar environment. pHDV is expected to range 
from 4.5 to 5.5. [53–55] Under these conditions, the doubly protonated form of chloroquine, 
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CQH22+, prevails over the monoprotonated (CQH+) and neutral (CQ) forms (Section S4 SI, Figure 
S18 SI). [56,57] Indeed, the tertiary amine and quinoline basic centres in CQ (Scheme I(a)) have 
respectively pKa ≈ 10.18 and ≈ 8.38, [58] even though a lower pKa (6.33) was also recently 
reported for the quinoline N atom. [54] Classical thermodynamic calculations show that the 
[CQH+]/[CQH22+] ratio steeply increases by one order of magnitude (from ≈ 1·10–4 to ≈ 1·10–3) as 
the pH rises from 4.5 to 5.5 (Figure S19(a) SI), while the neutral CQ form is always at least two 
order of magnitude more diluted than CQH+ (Figure S19(b) SI). Therefore, one may wonder 
whether enough monoprotonated drug, CQH+, is present in the DV to effectively complex heme 
according to the geometry here proposed (see above).  
To answer this question, it is worth noting that in the vacuolar environment free hematin 
(FePPIX(OH)H–) undergoes a strongly exothermic protonation to give the corresponding neutral 
FePPIX-water complex (FePPIX(H2O)H), which in turn might act as a reaction intermediate 
towards the heme:CQ adduct (reactions (2a-c)): 
CQH22+ + H2O  → CQH+ + H3O+     (2a) 
FePPIX(OH)H– + H3O+ → FePPIX(H2O)H + H2O     (2b) 
FePPIX(H2O)H + CQH+ → FePPIX(CQH)H+ + H2O       (2c) 
The latter sum to give the process (3): 
FePPIX(OH)H– + CQH22+ →  FePPIX(CQH)H+ + H2O                          (3) 
which is an acid-base reaction, coupled with a ligand exchange, between fully protonated 
chloroquine and free hematin. In other words, the monoprotonated minority form of drug, CQH+, 
may form upon complexation with heme and it is not strictly required that it acts itself as a 
reactant.  
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Table 4. Thermochemical data (kJ⋅mol–1) for reactions (2) and (3) at T = 298 K and p = 1 bar.a 
Reaction ∆rH∅ ∆rG∅ T·∆rS∅ 
(2a) 156.9 155.1 
152.0 
148.7 
4.9 
6.5 
(2b) -139.2 
-169.5 
-138.3 
-170.5 
-0.9 
1.0 
(2c) -85.5 
-116.4 
-49.2 
-80.0 
-36.3 
-36.5 
(3) -67.8 
-130.8 
-35.4 
-101.8 
-32.4 
-29.0 
a
 Thermochemical quantities are computed from the DFT electronic energies of reactants and products in 
water (first row) and n-octanol (second row) upon applying statistical thermodynamics corrections. 
 
Table 4 shows the thermochemical data associated to reactions (2a-c) and (3), as computed at the 
DFT-B3LYP 6-311G(p,d) level of theory. Individual values of the quantum mechanical electronic 
energies are listed in the SI (Section S5, Tables S32–S34). Strictly speaking, entries in Table 4 
refer to processes taking place among ideal gases of reagents and products [48] and therefore they 
cannot be directly compared with experimental outcomes. Yet, it is worth noting that our estimate 
for the reaction enthalpy of the overall reaction (3) among stable species in water (–16.2 kcal⋅mol–
1) is reasonably close to calorimetric measurements of heat associated to the heme:CQ binding 
process (–10(1) kcal⋅mol–1 at T = 37 °C and pH = 6.5 [59] and –7.9 kcal⋅mol–1 at T = 28 °C and 
pH = 5.6 [60]). 
Data in Table 4 show that processes (2a-c) are all enthalpy-driven, and so the overall reaction (3), 
as the entropy term is either immaterial (2a-b), or even unfavourable (2c). The entropy reduction 
associated to the ligand shift reaction (2c) is clearly due to the loss of conformational freedom 
experienced by the drug upon complexation, as strong CAHB interactions between the tertiary 
amine and the propionate moiety (Fig. 5) lock otherwise free torsion angles of the long 
hydrocarbon chain. In conclusion, reaction (3) is exergonic as the strongly exothermic acid-base 
process (2b) and the ligand shift reaction (2c) provide enough energy to pay the highly 
unfavourable deprotonation cost of the CQH22+ species (reaction (2a)).  
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When the same thermochemical parameters are computed from reactants and products optimized 
in n-octanol (Table 4), analogue conclusions hold true but the process (3) becomes significantly 
more favoured. This is due to a couple of concomitant effects. First, the neutral heme:water 
intermediate, FePPIX(H2O)H, is more stabilized (reaction (2b)) with respect to its charged 
reactants in the low-dielectric constant medium than in water (Table S34 SI); second, the ligand-
shift reaction (2c) becomes more exothermic as the apolar environment allow the strengthening of 
CAHB interactions (Figure 5, Tables S19–S20 SI). This is also consistent with EXAFS results 
(Figure 7). 
It should be also noted that the vacuolar pH range is ideal for promoting hemozoin crystallization. 
In fact, the two propionate groups of the FePPIX(OH)H2 scaffold have pKa = 4.3 and 5.5 [36]; 
free hematin is expected to exist mainly in either anionic FePPIX(OH)H– or neutral 
FePPIX(H2O)H form (reaction (2b)), where just the more acidic propionic function has lost its 
proton. Indeed, a single protonated carboxylic function per heme molecule (Scheme I(c)) is 
required to set up hydrogen-bonded chains in the hemozoin crystal. [16] Then, heme:CQ 
complexation is expected to be in competition with heme dimerization (4):  
2 FePPIX(H2O)H → FePPIX(FePPIX)H + 2 H2O        (4) 
The latter is strongly exothermic and exergonic, with ∆HØ (∆GØ) = –44.9 (–46.6) kcal·mol–1 and 
–52.7 (–55.0) kcal·mol–1 in water and n-octanol (see Table S34 SI). Therefore, a robust 
thermodynamic driving force exists towards heme dimerization. This evidence complies well with 
the slight preference showed by H EXAFS data for the heme dimer model (ii) (see above). At the 
same time, it also implies that the competition of CQ for the Fe axial position should be kinetic in 
nature. This is reasonable, as a ligand exchange reaction (2c), possibly conjugated with a proton 
transfer (3), is expected to occur faster than a concerted ligand exchange involving two water 
molecules on two Fe centres (4). It is also worth noting that the parasite employs a specific 
polymerase to speed up hemozoin crystallization. [19,20] This implies that heme self-assembly is 
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by itself a relatively slower process compared with possible antagonist reactions, such as 
extrusion of free heme from DV and/or complexation with CQ.  
 
4.4 On the reversibility of the direct Fe–N bond in the heme:CQ complex.  
There is consensus on the fact that free hematin is detrimental to the malaria parasites. 
Monomeric Fe-PPIX indeed produces oxidant ROS in the cytosol [12,13] (see the Introduction 
above), and it was also found to inhibit the malarial form of the enzyme lactate dehydrogenase. 
[21] To preserve the activity of the Fe3+ redox centre, it is mandatory that the axial position of the 
Fe-PPIX complex be not blocked irreversibly by any ligand. Binding of Fe(III) by propionate 
groups, followed by irreversible hemozoin crystallization (see Introduction), is indeed the 
detoxification mechanism adopted by the malaria parasite. Therefore, reversible heme:drug 
complexation is mandatory to account for the CQ antiplasmodial ability.  
It has been recently proposed that the heme:CQ complex is unstable in the parasite cytosol, where 
it might passively diffuse through the DV membrane following its natural concentration gradient. 
[61] The Plasmodium cytosol is weakly alkaline (pH ≈ 7.15(7)), [62] so in that environment the 
majority of free (FePPIX(OH)2–) and complexed (FePPIX(CQH)) heme molecules bear charged 
propionic groups. At the same time, the concentration of the CQH+ form of chloroquine is, on 
average, two order of magnitude higher than in the DV (Figure S18 SI). In these conditions, OH– 
ions can effectively shift CQH+ from the iron complex according to (5a–b): 
FePPIX(CQH) + H2O  → FePPIX(H2O)– + CQH+    (5a) 
 FePPIX(H2O)– + OH– → FePPIX(OH)2– + H2O   (5b) 
which sum to equation (6): 
FePPIX(CQH) + OH– → FePPIX(OH)2– + CQH+    (6) 
Table 5 shows the corresponding thermochemical data for processes (5) and (6). As expected, 
here the entropic term is favourable for the shift reaction (5a), as the released free drug can span a 
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larger portion of its accessible conformation space. However, it is again an exothermic acid-base 
reaction, (5b), which provides the enthalpic driving force for making the overall process (6) 
exergonic. 
Table 5. As Table 4 above for reactions (5) and (6) at T = 298 K and p = 1 bar.a  
Reaction ∆rH∅ ∆rG∅ T⋅∆rS∅ 
(5a) 99.6 71.2 28.5 
(5b) -265.4 -268.3 2.9 
(6) -165.7 -197.1 31.4 
a
 Reactants and products were optimized in water. 
In conclusion our thermochemical calculations, within the limits of the approximations here 
employed, demonstrate that the Fe–N direct interaction in the heme:CQ complex does not 
irreversibly block the Fe-PPIX redox centre, as the FePPIX(CQH) adduct is unstable with respect 
to exchange with OH– ions in the slightly alkaline conditions of the cytosol. 
CONCLUSIONS 
We investigated the interaction of the antimalarial drug chloroquine (CQ) with heme in acidic 1:1 
H2O:DMSO solutions at room temperature by EXAFS spectroscopy. The chemical composition 
of the solutions was set in order to reproduce as closely as possible the conditions within the 
digestive vacuole (DV) of the malaria parasite. EXAFS outcomes were also complemented by 
DFT simulations in water and n-octanol to provide an interpretative framework of the 
spectroscopic data and to investigate the thermochemistry of heme:CQ complexation. 
A broad consensus sustains the heme:CQ complexation as the core process of the drug activity 
against Plasmodium parasite. Heme:CQ adducts might indeed either cause direct damage to the 
parasite membranes, [22] or produce indirect damage by aiding toxic free heme [12,13] to be 
released into cytosol. As CQ interferes with hemozoin assembly, it makes more Fe-PPIX 
available to diffuse out of the DV either in its monomeric [12] or complexed [61] form. Heme:CQ 
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adducts are indeed expected to be unstable in the slight alkaline environment of the Plasmodium 
cytosol, [61] and our DFT calculations support this hypothesis.  
As for the nature of the heme:CQ complex, phase shifts detected in the EXAFS signal between 
CQ-containing and CQ-free hematin solutions suggest that, at least in the conditions here adopted, 
the first coordination shell of the iron ion is closely involved in the drug:substrate recognition 
process. We propose that a complex where the quinoline nitrogen of the drug is coordinated to the 
iron center might coexist with other possible (e.g. pi· · ·pi stacked) adduct geometries. It is the first 
time that a direct Fe-N bond, formerly hypothesized on the basis of solid-state NMR findings, 
[26] is observed in solution. However, the reader must be aware of the technical limits of the 
experiments we performed.  First, EXAFS spectra were collected at room temperature; therefore, 
thermal motion issues limit both the accuracy and the precision of the refined parameters. Second, 
the changes we found in EXAFS spectra are very small and do not allow to extract quantitative 
information on the nature of the heme:CQ complex(es). Nevertheless, trends in edge energies, 
difference signals and χ(R) functions are consistent throughout the whole pH series here explored 
and agree with the heme:CQ adduct model here proposed on the basis of EXAFS-aided DFT 
calculations. Obviously, the latter could be either confirmed or falsified by further experimental 
evidences. Low-T EXAFS experiments are in order to gain further insights into the interaction of 
AQ-class drugs with heme and a forthcoming paper will be devoted to this topic. 
In any case, DFT simulations demonstrate that charge-assisted hydrogen bonds (CAHBs) among 
the drug tertiary amine R3NH+ and the free propionate chain of the Fe-PPIX system are 
determinant in stabilizing the adduct. As expected, CAHBs are strengthened in a less polar 
environment. Therefore, the formation of the proposed heme:drug adduct should be favoured by 
the presence of lipid micelles. In conclusion, both the quinoline Nitrogen and the lateral chain of 
CQ are effective components of the drug pharmacophore and cooperate in determining its ability 
to hamper heme dimerization. 
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In computational works, the putative effectiveness of a CQ-like drug is often judged based on its 
heme-binding strength. [28] Anyhow, the ability of the drug to slow down heme self-recognition 
and self-assembly could be as much important as thermodynamics in determining the 
effectiveness of the antiplasmodial action. Therefore, provided that the CQ-induced toxicity is 
mainly due to free heme and not to interactions of the drug with other molecular targets, [21] it is 
not strictly mandatory that the heme:CQ adduct be the most stable on absolute grounds. Besides, 
with a regard to the inhibition kinetics determination, CAHBs might be even more crucial than 
direct interplay among the core moieties of the interacting molecules. These non-covalent 
interactions are ubiquitary in all the proposed heme:CQ interaction geometries [25,33,50,51]. In 
light of the described findings, it is plausible to consider the CAHBs strength engineering as an 
effective strategy towards the development of novel CQ-based antiplasmodials. 
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